Janux Therapeutics, Inc. (JANX) Tops Q4 EPS by 11c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q4 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Brookfield Wealth Solutions Ltd. (BNT) Reports Q2 EPS of $0.07
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance